List of works by Mondher Toumi

A critical analysis and review of Lancet COVID-19 hydroxychloroquine study

scientific article published on 10 September 2020

A tolerability burden index in schizophrenia: incorporating patient perspective in clinical trial adverse event reporting

scientific article published on 13 September 2017

Can we well assess the relative efficacy and tolerability of a new drug versus others at the time of marketing authorization using mixed treatment comparisons? A detailed illustration with escitalopram

scientific article

Characteristics of doctor-shoppers: a systematic literature review

article

Cultural differences in stigma surrounding schizophrenia: comparison between Central Europe and North Africa

scientific article published on 19 November 2015

Determining the value of medical technologies to treat ultra-rare disorders: a consensus statement.

scientific article published on 27 October 2016

Direct medical mental health care costs of schizophrenia in France, Germany and the United Kingdom - findings from the European Schizophrenia Cohort (EuroSC).

scientific article published on 28 March 2009

Economic burden for Alzheimer's disease in China from 2010 to 2050: a modelling study

scientific article published on 26 September 2019

Factors contributing to frequent use of psychiatric inpatient services by schizophrenia patients.

scientific article published in September 2004

Health economic evaluation of gene replacement therapies: methodological issues and recommendations

scientific article published on 11 October 2020

Health related quality of life in patients having schizophrenia negative symptoms - a systematic review

article

Health-related quality of life of patients after ischaemic stroke treated in a provincial hospital in Poland

scientific article published on 17 June 2020

Healthcare resource use in schizophrenia, EuroSC findings

scientific article published on 5 September 2017

Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders

scientific article

Non-profit drug research and development: the case study of Genethon

article

Patient preference for chronic obstructive pulmonary disease (COPD) treatment inhalers: a discrete choice experiment in France

scientific article published on 15 February 2019

Patient-reported outcome claims in European and United States orphan drug approvals

scientific article published on 07 November 2018

Positive and negative symptoms in schizophrenia: A longitudinal analysis using latent variable structural equation modelling

scientific article published on 31 August 2018

President Trump’s prescription to reduce drug prices: from the campaign trail to American Patients First

scientific article published on 04 March 2019

Psychosocial functioning, quality of life and clinical correlates of comorbid alcohol and drug dependence syndromes in people with schizophrenia across Europe

scientific article published on 26 March 2016

Quantifying the persisting orphan-drug shortage public health crisis in the United States

scientific article published on 23 December 2016

Supply-side and demand-side policies for biosimilars: an overview in 10 European member states.

scientific article

The Use of Surrogate and Patient-Relevant Endpoints in Outcomes-Based Market Access Agreements : Current Debate

scientific article published on 31 August 2016

The mediating role of depression in pathways linking positive and negative symptoms in schizophrenia. A longitudinal analysis using latent variable structural equation modelling

scientific article published on 08 March 2019

The perverse impact of external reference pricing (ERP): a comparison of orphan drugs affordability in 12 European countries. A call for policy change

scientific article published on 3 September 2017

Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines.

scientific article published on 26 July 2017

Why "American Patients First" is likely to raise drug prices outside of the United States

scientific article published on 09 August 2019